Usa Financial Portformulas Corp Vertex Pharmaceuticals Inc Transaction History

Usa Financial Portformulas Corp

$641 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	SELL	$392.81 - $485.53 $803,689 - $993,394	-2,046 Reduced 49.17%	2,115 $991,000
Q1 2024 Apr 30, 2024	SELL	$407.69 - $446.08 $929,125 - $1.02 Million	-2,279 Reduced 35.39%	4,161 $1.74 Million
Q4 2023 Feb 07, 2024	SELL	$343.0 - $410.68 $419,832 - $502,672	-1,224 Reduced 15.97%	6,440 $2.62 Million
Q3 2023 Nov 27, 2023	SELL	$338.18 - $362.46 $733,850 - $786,538	-2,170 Reduced 22.07%	7,664 $2.67 Million
Q2 2023 Nov 27, 2023	SELL	$314.42 - $351.91 $245,247 - $274,489	-780 Reduced 7.35%	9,834 $3.46 Million
Q1 2023 Nov 27, 2023	SELL	$283.23 - $323.1 $759,339 - $866,231	-2,681 Reduced 20.17%	10,614 $3.34 Million
Q3 2022 Oct 24, 2022	SELL	$273.83 - $305.53 $216,873 - $241,979	-792 Reduced 5.62%	13,295 $3.85 Million
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $3.31 Million - $4.12 Million	14,087 New	14,087 $3.97 Million
Q1 2022 Aug 16, 2022	SELL	$221.42 - $260.97 $2,878 - $3,392	-13 Closed	0 $0
Q2 2021 Jul 29, 2021	BUY	$187.49 - $221.1 $562 - $663	3 Added 30.0%	13 $3,000
Q1 2021 May 06, 2021	BUY	$207.02 - $241.31 $207 - $241	1 Added 11.11%	10 $2,000
Q4 2020 Jan 29, 2021	SELL	$207.01 - $276.09 $1.88 Million - $2.5 Million	-9,067 Reduced 99.9%	9 $2,000
Q3 2020 Oct 09, 2020	SELL	$255.65 - $303.1 $1.61 Million - $1.91 Million	-6,289 Reduced 40.93%	9,076 $2.47 Million
Q2 2020 Aug 11, 2020	BUY	$225.48 - $295.8 $156,934 - $205,876	696 Added 4.74%	15,365 $4.46 Million
Q1 2020 Apr 13, 2020	BUY	$199.77 - $247.81 $2.93 Million - $3.64 Million	14,669 New	14,669 $3.49 Million
Q1 2019 May 14, 2019	SELL	$163.73 - $194.7 $6.66 Million - $7.92 Million	-40,700 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$151.91 - $192.21 $6.18 Million - $7.82 Million	40,700 New	40,700 $7.85 Million
Q4 2017 Feb 13, 2018	SELL	$137.28 - $155.55 $5.49 Million - $6.22 Million	-39,969 Closed	0 $0
Q3 2017 Nov 02, 2017	SELL	$148.13 - $162.24 $5,925 - $6,489	-40 Reduced 0.1%	39,969 $6.08 Million
Q3 2017 Oct 11, 2017	BUY	$148.13 - $162.24 $2.54 Million - $2.78 Million	17,139 Added 74.94%	40,009 $6.08 Million
Q2 2017 Aug 23, 2017	BUY	N/A	22,870	22,870 $2.95 Million

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

Capital World Investors Los Angeles, CA

26.7M
Shares

$13.4 Billion
2.1% of portfolio
Vanguard Group Inc Valley Forge, PA

23M
Shares

$11.5 Billion
0.21% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$10.7 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.7M
Shares

$5.89 Billion
0.24% of portfolio
Capital Research Global Investors Los Angeles, CA

8.54M
Shares

$4.29 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Usa Financial Portformulas Corp, based on Form 13F filings with the SEC.

News

Stay updated on Usa Financial Portformulas Corp with notifications on news.

Account